This week's roundup of Houston innovators includes Tammi Wallace of the Greater Houston LGBT Chamber of Commerce, Adam Putterman of OURS, and Ghazal Qureshi of UpBrainery. Courtesy photos

Editor's note: In this week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — from edtech to mental health — recently making headlines in Houston innovation.

Tammi Wallace, co-founder of the Greater Houston LGBT Chamber of Commerce

Tammi Wallace of the Greater Houston LGBT Chamber of Commerce was a panelist on The Ion's Pride in Tech event. Photo via LinkedIn

There are a few days left in Pride Month, and Houston's tech community came together last week to celebrate — but also discuss some of the challenges within the ecosystem for LGBTQIA+ entrepreneurs.

In a Q&A with InnovationMap, Tammi Wallace, co-founder of the Houston LGBT Chamber of Commerce, shared her advice for LGBTQIA+ innovators and allies.

"Get involved with the Houston LGBT Chamber of Commerce," she says. "Since 2016, the chamber has been working to build a strong community to support LGBTQIA+ entrepreneurs and get them access to resources to help their businesses grow and thrive." Click here to read more.

Adam Putterman, co-founder of OURS

Adam Putterman, co-founder of OURS, shares how he jumped on the opportunity that is innovating the future of relationship health. Photo courtesy of OURS

More than ever before, people are warming up to the idea of seeking professional health care for more than just their bodies, Adam Putterman, co-founder of OURS says on the most recent episode of the Houston Innovators Podcast.

"We've seen a massive shift in the perception of counseling and therapy — and, more importantly, all the aspects of health that are not just your body," he explains. "It's no longer just going to the gym, it's meditating, coaching for a professional field. We've found that people are taking that mindset and applying it to their relationship as well."

After launching its beta in 2020, OURS worked in stealth to develop its product, which officially launched in May. The platform costs $400 for a four-week program that includes six personalized interactive sessions with an OURS guide at the helm of the experience. These one-hour technology-powered sessions are based around an innovative new technology, called Loveware, and include dynamic and meaningful conversations between a couple that are built around the magic that comes from being in the room with an expert. Click here to listen to the full episode and read more.

Ghazal Qureshi, founder and CEO of UpBrainery

Innovations like artificial intelligence, augmented reality, and machine learning certainly have advantages in the edtech sector. Photo courtesy

The education community is facing big changes thanks to technology and new innovations. In a guest column for InnovationMap, Ghazal Qureshi — founder and CEO of UpBrainery, a Houston-based immersive educational technology platform — shares how things like artificial intelligence, machine learning, and more have the potential to impact the sector.

"AI has created benefits for educators as well, such as it has created a task automation system in which all kinds of daily mundane tasks including grading papers, admin work, replying to queries, etc. have been directly automated," she writes. "Although adopting cutting-edge technology in the educational industry for most institutions is certainly not a piece of cake as it is time-consuming and very costly." Click here to read more.

Adam Putterman, co-founder of OURS, shares how he jumped on the opportunity that is innovating the future of relationship health. Photo courtesy of OURS

How this Houston innovator plans to disrupt the $5 trillion health and wellness market

HOUSTON INNOVATORS PODCAST EPISODE 139

When in graduate school, Houstonian Adam Putterman's interest in couples counseling was officially piqued. A newlywed, Putterman always thought couples sought out professional help as a way to save a relationship that was failing, but studies were showing the positive effect of proactive couples counseling.

Putterman says he connected with a professor who wrote a book on the topic, which explained that the average relationship was much worse than it had ever been.

“We have so many higher expectations than ever before, but so much fewer support systems and ways to invest in your relationships,” he says on this week's episode of the Houston Innovators Podcast.

This information stuck in his head until he met his would-be co-founders Liz Earnshaw and Jessica Holton. Together, the trio established OURS, a modern relationship health platform for couples to receive customized virtual support.

More than ever before, people are warming up to the idea of seeking professional health care for more than just their bodies, Putterman says.

"We've seen a massive shift in the perception of counseling and therapy — and, more importantly, all the aspects of health that are not just your body," he explains. "It's no longer just going to the gym, it's meditating, coaching for a professional field. We've found that people are taking that mindset and applying it to their relationship as well."

After launching its beta in 2020, OURS worked in stealth to develop its product, which officially launched in May. The platform costs $400 for a four-week program that includes six personalized interactive sessions with an OURS guide at the helm of the experience. These one-hour technology-powered sessions are based around an innovative new technology, called Loveware, and include dynamic and meaningful conversations between a couple that are built around the magic that comes from being in the room with an expert.

Right now, the program targets premarital counseling, but Putterman says OURS is working to provide support for all stages of a relationship

"Proactive and preventative is always better. It's easier to do and it's more impactful," he says. "That's one of the reasons why we're focused on premarital counseling — one of the happiest, earliest moments in any relationship."

Along with emerging from stealth last month, OURS announced $5 million in early stage funding from investors including TMV, Serena Ventures, Lakehouse Ventures, Collaborative Fund, GreyMatter, and pioneering angel investors such as Andy Dunn.

Now, Putterman says the company is using that funding to further develop its team and product. OURS is headquartered in Houston, and Putterman is based here, but the company operates entirely remotely.

He share more of what OURS is working on now and in the near future. Listen to the interview below — or wherever you stream your podcasts — and subscribe for weekly episodes.


OURS is re-imagining and de-stigmatizing couples therapy. Photo by Mikhail Nilov/Pexels

Houston-based mental health startup backed by Serena Williams emerges from stealth

smart counseling

A Houston startup that's re-imagining mental health treatment and counseling has emerged from stealth, announcing financial support from seed investors including tennis legend and venture capital investor Serena Williams.

Targeting the $5 trillion health and wellness market, OURS is founded by family therapist and author Liz Earnshaw, as well as Adam Putterman and Jessica Holton.

“We’re excited to take this first step in shifting the way we think about relationship health. We are building for a world that treats relationship health with equal importance as physical, mental and emotional health. We want working on your relationships to be an everyday experience, accessible to all,” says Holton, who serves as co-CEO, in a news release.

The company has raised nearly $5 million pre-seed and seed round from investors including TMV, Serena Ventures, Lakehouse Ventures, Collaborative Fund, GreyMatter, and pioneering angel investors such as Andy Dunn.

“Research shows that relationships are the most important factor to our overall health and wellbeing, which is an area that I'm hyper-focused on in my personal life,” says Williams, managing partner of San Francisco-based Serena Ventures, in the release. “When I learned about what the team was doing, I knew this was something we needed to support.

"OURS offers a reimagined and preventative solution to relationship wellness that's not only experiential and research-backed, but memorable and fun," she continues. "We're proud to be early investors in a brand that is making relationship health accessible to couples everywhere and play an integral part of the larger OURS mission.”

OURS has thousands of couples already using its platform. Image via OURS

The company launched its beta in 2020 and has already worked with thousands of customers and has an engaged community of couples across its platforms.

The OURS founders were inspired by their own experiences with couples counseling and created a technology-enabled platform based of expert and data-backed research.

“As it stands, the current mental health and wellness space is largely geared towards individuals, yet nearly 50 percent of couples have either participated in, or have sought out solutions, to foster stronger romantic partnerships,” says Soraya Darabi, co-founder and general partner at TMV, in the release. “However, a lack of therapists - until now - or confused perception of couples counseling leave needs unmet.”

Initially targeting romantic partners, the platform costs $400 for a four-week program that includes six personalized interactive sessions with an OURS guide at the helm of the experience. These one-hour technology-powered sessions are based around an innovative new technology, called Loveware, and include dynamic and meaningful conversations between a couple that are built around the magic that comes from being in the room with an expert.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston researchers report promising first in-human trial for implantable cancer therapy

cancer breakthrough

When it comes to cancer remedies, the treatment can be as challenging for the body as its cause. But what if immunotherapy could be localized? That’s precisely what a Houston team may soon make a reality.

Rice University researchers, in partnership with MD Anderson Cancer Center, recently published their findings from the first in-human trial of an implantable cancer-fighting treatment in the journal Clinical Cancer Research. The paper details testing of AVB-001, encapsulated cells engineered to release interleukin-2 (IL-2)—a naturally occurring signaling protein that boosts immunity—in the peritoneal cavities of 14 patients. The goal is to avoid the toxicity usually experienced with less targeted treatments, as well as find a solution to IL-2s’ abbreviated half-lives.

“Traditional IL-2 therapy has shown potent antitumor activity, but its clinical use has been limited by severe side effects and delivery challenges,” Omid Veiseh, director of the Rice Biotech Launch Pad, professor of bioengineering at Rice and a senior author on the study, said in a press release. “This platform allows us to localize and sustain cytokine exposure directly where tumors reside while minimizing systemic toxicity.”

Serous ovarian carcinoma is especially well-suited to the use of AVB-001 because it tends to spread throughout the abdomen. After a minimally invasive laparoscopic procedure, patients implanted with the cells were noted to tolerate the treatment well. Half of the enrolled patients’ cancer was stabilized, with several among them reporting extended signs of benefit. No maximum tolerated dose was reached and there were no life-threatening events tied to the study.

If that sounds like less-than-earth-shaking results, this is only the beginning. The capsules were implanted for about one week because IL-2 activity drops off after that. The researchers now know that further testing should include either higher levels, repeated doses, or a combination thereof, in order to create stronger advances.

The team has already made early headway on this next step. Preclinical studies in nonhuman primates were not only tolerated well, but without added toxicity, the apes had consistent pharmacological effects.

“This is a foundational step,” Veiseh explained. “We now have evidence that the platform is safe, biologically active and potentially scalable. The next phase is optimizing dosing and exploring combination therapies to unlock its full clinical potential.”

The combination would also include a checkpoint inhibitor, which might improve AVB-001’s tumor-fighting power. “What is exciting is that we are not just delivering a drug, we are programming a microenvironment,” added Dr. Amir Jazaeri, professor of gynecologic oncology at MD Anderson, member of the Rice Biotech Launch Pad’s clinical advisory board and a senior author on the study. “This opens the door to combination strategies that could amplify immune responses in ways that have not been feasible before.”

Houston startup raises $6M to scale home-based healthcare platform

fresh funding

As healthcare systems race to expand care beyond hospitals and into the home, investors are placing bigger bets on the infrastructure needed to make that shift possible.

This month, Rosarium Health announced it has raised $6 million in seed funding led by Kalos Ventures, with participation from ResilienceVC, Rock Health Capital, Symphonic Capital, Black Tech Nations Ventures and others.

The investment will help the Houston-based startup continue to build its platform, which features a national network of 800-plus clinicians and 3,000-plus contractors to coordinate home accessibility upgrades and modifications for seniors and people living with disabilities.

For founder and CEO Cameron Carter, the company’s mission grew out of firsthand caregiving experiences.

“From my own personal caregiving experiences, I realized that the benefits exist on paper, but not in reality,” Carter said in a news release. “Families are being left to figure out the paperwork and installations all on their own, which shouldn’t be how this works.”

While Medicare Advantage and Medicaid plans have expanded coverage for home-based services and accessibility modifications, the logistics behind delivering those services often remain fragmented.

Rosarium’s platform coordinates the entire process, from clinical assessments and referrals to contractor management, documentation, reimbursement and installation.

“A clinician can document that a home isn’t safe and a plan can approve a benefit, but there’s no one that’s responsible for making sure the work actually gets done,” Carter says. “We built the missing piece.”

The company was founded in 2021 as Rose Health and was a 2023 participant in the Texas Medical Center’s Accelerator for HealthTech program. It has scaled quickly, building a network of more than 800 clinicians and 3,000 contractors across 34 states.

Rosarium is currently in-network for 1.2 million Medicare and Medicaid lives, with projected coverage expected to reach nearly 4 million by the end of the year, according to the release.

“We’re excited to back Cameron because he and the team at Rosarium are building the infrastructure healthcare needs right now to make the home a safe and comfortable place of care,” Kate Ballinger, investor at Kalos Ventures, added in the release.

As part of the recent investment, Ballinger will join Rosarium’s board of directors.

With eyes on the future, Rosarium plans to grow its partnerships with Medicaid and Medicare Advantage plans, including CalViva and Community Health Plan of Imperial Valley, strengthening its presence in California while expanding access to underserved communities.

Additionally, Carter predicts that home-based healthcare will be part of a broader transformation happening across the industry.

“There’s a growing recognition that health outcomes are shaped by what happens in the home,” he said in the release. “The future of healthcare isn’t just treating people after something goes wrong. It’s creating environments that help prevent those problems in the first place.”